Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease

Pediatr Int. 2015 Oct;57(5):990-2. doi: 10.1111/ped.12679. Epub 2015 Jul 14.

Abstract

Coronary artery aneurysms (CAA) may occur in Kawasaki disease (KD). Patients with giant CAA (diameter >8 mm), in particular, have higher risk of myocardial infarction. Previous reports have demonstrated the necessity of anticoagulation therapy in such cases. The management of patients with KD complicated by giant CAA later in life, however, remains controversial. Here, we describe the strict management in the case of a 28-year-old pregnant Japanese woman with KD with giant CAA (diameter, 11 mm). Instead of warfarin, the patient was given low-dose aspirin and i.v. unfractionated heparin during pregnancy to prevent thrombosis in the giant CAA. At 38 weeks of gestation, she had spontaneous delivery of a healthy baby. No thrombotic or bleeding complications were observed. The strict anticoagulation therapy resulted in successful pregnancy and delivery without any adverse events.

Keywords: Kawasaki disease; coronary aneurysm; low-dose aspirin; pregnancy; unfractionated heparin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Computed Tomography Angiography
  • Coronary Aneurysm / diagnosis
  • Coronary Aneurysm / etiology*
  • Coronary Aneurysm / therapy
  • Coronary Vessels / diagnostic imaging*
  • Disease Management*
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Mucocutaneous Lymph Node Syndrome / complications
  • Mucocutaneous Lymph Node Syndrome / diagnosis
  • Mucocutaneous Lymph Node Syndrome / therapy*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular*
  • Pregnancy Outcome